Have a personal or library account? Click to login
Simvastatin is effective in killing the radioresistant breast carcinoma cells Cover

Simvastatin is effective in killing the radioresistant breast carcinoma cells

Radiology and Oncology
Volume 55 (2021): Issue 3 (September 2021)
By: Bertram Aschenbrenner,  Giulia Negro,  Dragana Savic,  Maxim Sorokin,  Anton Buzdin,  Ute Ganswindt,  Maja Cemazar,  Gregor Sersa,  Sergej Skvortsov and  Ira Skvortsova  
Open Access
|May 2021

Authors

Bertram Aschenbrenner

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Moscow, Russia

Giulia Negro

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Moscow, Russia

Dragana Savic

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Moscow, Russia

Maxim Sorokin

EORTC PathoBiology Group, Moscow, Russia
Institute of Personalized Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
Omicsway Corp, Walnut, USA
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia

Anton Buzdin

EORTC PathoBiology Group, Moscow, Russia
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
Oncobox ltd, Moscow, Russia
World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia

Ute Ganswindt

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria

Maja Cemazar

EORTC PathoBiology Group, Moscow, Russia
Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia

Gregor Sersa

Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia

Sergej Skvortsov

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria

Ira Skvortsova

Ira.Skvortsova@i-med.ac.at

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Moscow, Russia
DOI: https://doi.org/10.2478/raon-2021-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 305 - 316
Submitted on: Mar 10, 2021
|
Accepted on: Apr 2, 2021
|
Published on: May 4, 2021
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
breast cancer cells,
cancer stem cells,
radiotherapy,
migration,
simvastatin
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2021 Bertram Aschenbrenner, Giulia Negro, Dragana Savic, Maxim Sorokin, Anton Buzdin, Ute Ganswindt, Maja Cemazar, Gregor Sersa, Sergej Skvortsov, Ira Skvortsova, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 55 (2021): Issue 3 (September 2021)Next article